BOLD - Pangali Forward P/E boundlessbio.com
Boundless Bio, Inc. (BOLD) develops targeted cancer therapies through ecDNA analysis, protecting its capital with patents. The change in the company's expected P/E ratio demonstrates value dynamics relative to earnings, where 0.00 captures the current state of the parameter. Financial success is based on the rollout of inhibitors for oncology patients. The brand's visionary image and the trust of the scientific community confirm the breakthrough status of its developments in the fight against resistant tumors.
Rincian analitis lan laporan data perusahaan Boundless Bio Inc (BOLD)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas Boundless Bio, Inc.|BOLD - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Boundless Bio, Inc.|BOLD - Gunggung kewajiban utang perusahaan|Utang marang nilai buku Boundless Bio Inc.|BOLD - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Boundless Bio|Rasio cepet boundlessbio.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
BOLD - Asil keuangan resik|Bathi sing dikarepake Boundless Bio, Inc.|BOLD - Kapitalisasi marang bathi|Prakiraan rega marang bathi Boundless Bio, Inc|BOLD - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Boundless Bio Inc.|BOLD - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Boundless Bio|BOLD - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan boundlessbio.com|BOLD - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Boundless Bio, Inc.
Analisis dhasar perusahaan:Boundless Bio BOLD
The efficiency of ecDNA diagnostics and the success of CHK1 inhibitor trials directly determine the future cash flows of Boundless Bio, Inc. (BOLD). By analyzing the company's current forward P/E, an investor assesses the market value of the shares relative to expected earnings, allowing for a real-time assessment of shifts in confidence regarding management's strategy and an evaluation of the risk of overpayment should actual results deviate from forecasts.
Pesaing langsung
Rega marang bathi mangsa ngarep Tempus Labs (TEM)|Qiagen NV - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E IONS (Ionis Pharma)|RGEN: Rasio rega marang bathi mangsa ngarep|RNA - Rega marang bathi mangsa ngarep|CRSP: Rega marang bathi mangsa ngarep|WGS: Pangali Forward P/E|Rasio prakiraan rega marang bathi Ultragenyx Pharmaceutical Inc. (RARE)|Rega marang bathi mangsa ngarep Beam Therapeutics Corp|Sarepta Corp (SRPT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Twist Bioscience (TWST)|Kapitalisasi marang proyeksi bathi 10xgenomics.com|Intellia Therapeutics, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi STOK|BioLife Corp - Pangali Forward P/E|WVE: Rega marang bathi mangsa ngarep|MAZE: Pangali Forward P/E|SION - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Prime Medicine|Rasio prakiraan rega marang bathi Taysha Gene Therapies Inc TSHA|Prakiraan rega marang bathi QURE (uniQure Corp)|MGTX (MeiraGTx Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RGNX (REGENXBIO Inc.)|Kapitalisasi marang proyeksi bathi solidbio.com (SLDB)|OCGN - Rega marang bathi mangsa ngarep|PACB (Pacific Biosciences of California, Inc.) - Rasio rega marang bathi mangsa ngarep|BNTC: Pangali Forward P/E|Prakiraan rega marang bathi Design Corp|Prakiraan rega marang bathi RCKT|4dmoleculartherapeutics.com (FDMT) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E LXEO|Rega marang bathi mangsa ngarep KRRO (korrobio.com)|Rega marang bathi mangsa ngarep Editas EDIT|Silence Therapeutics Corp (SLN) - Rasio prakiraan rega marang bathi|PRQR - Rega marang bathi mangsa ngarep|CDXS: Rega marang bathi mangsa ngarep|SGMO: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep NAUT|MGX (Metagenomi, Inc) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep DTIL (Precision BioSciences Inc.)|Rega marang bathi mangsa ngarep Generation Bio Co. (GBIO)|exicuretx.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E IMNN (Imunon)|Pangali Forward P/E Phio Pharmaceuticals Corp PHIO|Mustang Bio Corp - Pangali Forward P/E|RNAZ: Rega marang bathi mangsa ngarep|bionanogenomics.com (BNGO) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi adnas.com (APDN)|Prakiraan rega marang bathi BLUE|Pangali Forward P/E ImmunoPrecise|Rega marang bathi mangsa ngarep Omega (OMGA)|Singular Genomics Corp - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E RGLS (Regulus Therapeutics)|SYRS: Rasio rega marang bathi mangsa ngarep|TBIO - Rega marang bathi mangsa ngarep|TCON: Rega marang bathi mangsa ngarep|UBX: Pangali Forward P/E
